Introduction
During the development of cardiac fibrosis, as well as fibrosis in other tissues, e.g. renal fibrosis, the extra deposition of collagen is accompanied by the appearance and anatomical coincidence in the fibrotic tissue of high concentrations of transforming growth factor-β 1 (TGF-β 1 ), angiotensin-converting enzyme (ACE) and myofibroblasts. 1, 2 In vivo and in vitro experiments have revealed that TGF-β 1 is the main growth factor responsible for the deposition of tissue collagen and other proteins of the extracellular matrix, leading to the development of fibrosis. 1, 3 Normal myocardium, remote from blood vessels, contains a low density of ACE. 4 However, pericardial, endocardial and interstitial fibrosis of the right ventricle and fibrosis at the site of myocardial infarction (MI) are always accompanied by the appearance of high tissue densities of ACE. 2, [5] [6] [7] In accordance with the appearance of ACE, the tissue concentration of angiotensin II (Ang II) at the site of MI is also increased several-fold compared with normal myocardium. 8 ACE in fibrotic tissue and in scars after MI is located in myofibroblasts. 7, [9] [10] [11] Myofibroblasts, as compared with fibroblasts, are larger, contain more protein per cell, [12] [13] [14] [15] [16] as well as intensively developed granular endoplasmic reticulum 17 and filaments of α-smooth muscle cell actin (α-SMA). 17, [18] [19] [20] Ang II and TGF-β 1 generate cardiac fibrosis. [21] [22] [23] [24] [25] Both TGF-β 1 and ACE, as a means of Ang II synthesis, are thus involved in the development of cardiac tissue fibrosis. The mechanisms by which Ang II and TGF-β 1 are synthesised in ventricular tissue may be related. Indeed, it has been found that Ang II alone induces the synthesis of TGF-β 1 in cultured fibroblasts. [26] [27] [28] [29] [30] [31] However, the effect of TGF-β 1 by itself on the appearance in fibroblasts of ACE and Ang II has not yet been studied.
TGF-β 1 is a potent inducer of the differentiation of fibroblasts, derived from different organs, [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] including the heart, 34, 39, 43 to myofibroblasts. In vivo, the appearance of myofibroblasts depends, not only on cytokine stimulation, but also on extracellular matrix organisation. 20 The appearance of ACE in myofibroblasts in fibrotic tissue may also be the Transforming growth factor-β β 1 induces angiotensinconverting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts Victor V Petrov, Robert H Fagard, Paul J Lijnen result of the combined action of multiple factors.
The mechanism(s) underlying the relationship between the appearance in tissue of TGF-β 1 and ACE is still unknown.The purpose of this study was to elucidate whether TGF-β 1 can induce in vitro synthesis of ACE in rat cardiac ventricular fibroblasts during their differentiation to myofibroblasts.
Material and methods Materials
Dulbecco's Modified Eagle's Medium (DMEM), streptomycin/penicillin, foetal bovine serum, versene and cellware were purchased from Gibco BRL (Life Technologies Ltd., Paisley, UK). Joklik's medium and protease inhibitors (antipain, aprotinin, bestatin, chymostatin, diprotin A, leupeptin, pepstatin-A, 1,10-phenanthroline, phenylmethylsulphonyl fluoride, sodium fluoride, sodium orthovanadate, N-α-p-tosyl-l-arginine methyl ester) were obtained from Sigma Chem. Co. (St. Louis, Missouri, USA) and phosphoramidon from ICN Pharmaceutical Inc. (Costa Mesa, CA, USA). Lisinopril was a gift from AstraZeneca (Belgium). Angiotensin-converting enzyme (ACE), sodium dodecyl sulphate, dithiothreitol, collagenase A, and n-propyl gallate were obtained from Sigma Chem. Co. Moviol was obtained from Calbiochem-Novabiochem Corp. (San Diego, CA, USA). Transforming growth factorβ 1 was obtained from Becton Dickinson Immunocytochemistry System (San Jose, CA, USA).
Isolation of cardiac fibroblasts
Cardiac ventricular fibroblasts were obtained from male Wistar rats, seven to eight weeks old and weighing about 200 g, using a slightly modified isolation procedure as described by Brilla et al. 44 In brief, rats were heparinised (625 units/ 100 g body weight), anaesthetised intraperitonially with nembutal 50 mg/100 g body weight.The heart was removed and placed immediately in sterile Joklik's medium. The extirpated hearts were allowed to eject the residual blood and the aorta was cannulated. A syringe was filled with a small volume of basic salt solution containing NaCl, 130 mM, KCl, 3 mM, KH 2 PO 4 , 1.2 mM, MgSO 4 , 1 mM, CaCl 2 , 1.25 mM, glucose, 10 mM, HEPES, 10 mM, at pH 7.2 and the cannula flushed to rinse blood out of the heart. The hearts were then perfused via the ascending aorta according to the Langendorff method 45 with Joklik's medium for 5 minutes, then by recirculating Joklik's medium containing 0.02% collagenase A and 2% bovine serum albumin (BSA) for 35 minutes with a flow of 5 ml/minute. Thereafter, the atria and vessels were cut off and the ventricular tissue placed in Joklik's medium containing 1% BSA and 0.01% collagenase A for an additional 10 minutes (37°C).The tissue was then minced and filtered through a 200 µM mesh net.
Cell cultures
The coarse cell/disintegrated tissue suspension was settled for 15 minutes and the supernatant was then centrifuged at 350 g for 10 minutes.The pellet was resuspended in DMEM supplemented with 10% foetal bovine serum (FBS), and 1% of peni-cillin/streptomycin solution and seeded in a 80 cm 2 tissue culture flask.The cell cultures were then preincubated at 37°C in humidified air (humidity 95%) with 5% CO 2 for 4 hours. The medium with unattached cells was aspirated and fresh DMEM supplemented with 10% FBS and penicillin/streptomycin added. The cultures were examined daily, using phase-contrast microscopy. The medium was replaced every two to three days and the cells were grown to confluence and then passaged with trypsin-EDTA. Under these conditions of isolation, coronary smooth muscle and endothelial cells were already rarely seen in the primary cultures. Myocytes do not survive the isolation method, since oxygenation is not provided. In the present study, only cardiac fibroblasts from passage two were used. For the second passage, cells were transferred to six-well dishes in DMEM with 10% FBS at a density of 2600 cells/dish. After 24 hours, the medium was replaced with fresh DMEM with 10% FBS containing transforming growth factor-β 1 (10 ng/ml) and incubated for one to seven days.
Immunocytochemistry
Immunofluorescence was performed in slides (Becton-Dickinson). The cells were fixed in methanol at -20°C for 5 minutes. After blocking the non-specific binding with 0.5% BSA, the cells were incubated at 37°C for 1 hour with primary antibodies (Ab) : monoclonal mouse anti-vimentin Ab, clone V9 (Dako, Glosstrud, Denmark) diluted 1/10; monoclonal mouse anti-desmin Ab (Dako), clone D33, diluted 1/10; monoclonal mouse antifactor VIII Ab (Dako), clone F8/86, diluted 1/10; monoclonal mouse anti-α-smooth muscle actin Ab (Sigma Chem. Co.), clone 1A4, diluted 1/500; monoclonal mouse anti-ACE Ab (Chemicon,Temecula, CA, USA), clone 9B9, diluted 1/10-1/100.The cells were then washed with phosphate buffered saline and incubated for a further hour with an antimouse IgG, conjugated with fluoresceine isothiocyanate (Sigma Chem. Co.), diluted 1/100. Secondary Ab was also added to cells without primary antibody to check for non-specific binding. Finally, the cells were washed with phosphate buffered saline and mounted in Moviol, solved in Tris-HCl buffer (pH 8.5) with glycerol and npropyl gallate.Visualisation was performed by the use of an inverted Leica-Leitz microscope DMIRB (Leica AG, Heerbrugg, Switzerland) and the cells were photographed on Fujicolor CZ 135.
Western blotting
Washed fibroblasts were lysed in Tris-HCl buffer (pH 7.5) containing sodium dodecylsulphate (SDS, 2%), dithiothreitol (1%), phenylmethylsulphonyl fluoride (1 mM), leupeptin (2 µg/ml), pepstatin (2 µg/ml), sodium fluoride (10 µM), sodium orthovanadate (1 mM) and N-α-p-tosyl-L-arginine methyl ester. The cell lysates were boiled for 3 minutes and sonicated at 4°C for 30 seconds. The insoluble material was removed by centrifugation at 12,000 g for 15 minutes. Aliquots were electrophoretically fractionated with Phast System (Amersham Pharmacia Biotech, Roosendaal, The Netherlands) on 4-15 gradient SDS-PAGE mini-gels and electro-blotted onto a nitrocellulose membrane. The membrane was sequentally incubated in 5% Blocker (Bio-Rad Laboratories, Hercules, CA, USA) for 1 hour. The membrane was then incubated for 2 hours with primary antibodies, monoclonal mouse antivimentin Ab, clone V9 (Dako) diluted 1/1000; monoclonal mouse anti-desmin Ab (Dako), clone D33, diluted 1/100; monoclonal mouse anti-factor VIII Ab (Dako), clone F8/86, diluted 1/100; monoclonal mouse anti-α-smooth muscle actin Ab (Sigma Chem. Co.), clone 1A4, diluted 1/1000; monoclonal mouse anti-ACE Ab (Chemicon), clone 9B9, diluted 1/300. The blot was washed and incubated with horse peroxidase-coupled goat anti-mouse IgG (Bio-Rad Laboratories) secondary antibody (dilution 1/6000), washed and the band visualised by incubation of the blots with substrate (Bio-Rad Laboratories) for peroxidase. Densitometric analysis was performed using a Sharp scanner JX-325 and a Software Image Master (Amersham Pharmacia Biotech). 3 H-thymidine incorporation was measured in growing cultures of fibroblasts as previously described. 46 5-Bromo-2'-deoxyuridine (BrDu) was measured with a colorimetric immunoassay (Roche Diagnostics GmbH, Germany).The number of cells in the culture was counted with a haemocytometer or with a microtitre tetrazolium assay, WST-1 (Roche Diagnostics).
Cardiac fibroblast growth

Assay of angiotensin-converting enzyme
The fluorimetric assay for ACE in cardiac fibrob- lasts is based on the conversion of the substrate analog hippuryl-histidyl-leucine to hippurate and L-histidyl-leucine, which is quantified spectrofluorimetrically (λ excitation = 360 nm, λ fluorescence = 500 nm). Fibroblasts, following culture with or without TGF-β 1 for seven days, were lysed. Lysates of fibroblasts were prepared by freezing-thawing (three times) of the harvested cells in the presence of 1.8% Triton X-100. To remove the debris, the suspension was centrifuged at 10,000 g for 15 seconds. Aliquots of the supernatants were then incubated in the presence of 5 mM substrate, hiplis-leu, in the presence or absence of lisinopril, at pH 8.3 and at 37°C in a thermomixer (Eppendorf), for 18 hours.The appearance of the dipeptide hisleu was then measured in the presence of 0.1% o-phthaldialdehyde. 47, 48 Measurement of cell size Cell size was quantified by cell volume, surface area and cell protein concentration of freshly trypsinised cells. 49, 50 Cell volume was quantified by measuring the diameter of trypsinised cells. 49 Cell surface area was obtained by scanning (Sharp scanner JX-325) the photographs of the cells in the haemocytometer and calculated using a Software Image Master (Amersham Pharmacia Biotech).
Statistical analysis
Values are expressed as means ± SEM.The statistical methods used are repeated measures analysis of variance and Student's two-tailed test for paired data and a p-value < 0.05 is considered statistically significant.
Results
Characterisation of fibroblasts in culture
The results of phase-contrast light microscopy ( Figure 1) show that cultures of rat cardiac fibroblasts have morphological characteristics typical of fibroblasts in culture and do not show structures typical of vascular smooth muscle cells (VSMC) (e.g. 'hill and valley' features) or for endothelial cells (e.g.'cobblestone' features). 51 Immunostaining and Western blotting show that cell cultures contain vimentin, a marker of fibroblast-like cells, but do not contain desmin or factor VIII, markers of VSMC and endothelial cells, respectively (data not shown).
In initial phases the cultures contained more elongated cells. As cultures approach confluence, more stellar-shaped cells appear whilst in confluent cultures round cells predominate.This is compatible with data obtained by others. 52, 53 Thus, our cultures consist of fibroblast-like cells and are free of VSMC and endothelial cells. The cultures of fibroblasts incubated with TGF-β 1 are always less confluent and have a structure different that of control cell cultures (comparisons shown in 
Angiotensin-converting enzyme (ACE) and 'ACE-like' activity in fibroblasts cultured with(out) TGF-β β 1 Activity of hip-his-leu degradation in control cultures
The total activity of hip-lis-leu degradation in homogenates of the control cultures of fibroblasts was 31.8 ± 5.7 pmol/(min x 10 6 cells) ( Table 1) .A Figure 2 Dose-dependence of the inhibition of ACE by lisinopril in homogenates of control ( ) and TGF-β 1 treated (•) fibroblasts.Adult rat cardiac ventricular fibroblasts at passage two are incubated for seven days in a DMEM medium supplemented with 10% foetal bovine serum with(out) 10 ng/ml TGF-β 1 . Lisinopril is added to the cell homogenates at different concentrations (10 -10 to 10 -5 M). Table 1 Total activity, lisinopril-dependent activity or ACE activity and lisinopril-independent activity or ACE-like activity in control and TGF-β 1 -treated cardiac fibroblasts.
Activity of hip-his-leu degradation Control TGF-β 1 -treated cells Fold increase from basal pmol his-leu/(min x 10 6 cells)
Total activity (n = 9) 31.8 ± 5. specific ACE inhibitor, lisinopril, added to the homogenates inhibited the degradation of hip-hisleu in a dose-dependent manner (p<0.001) with a maximal effect at 0.1 µM.
Increasing the concentration of lisinopril to 10 µM was not accompanied by a further inhibition of the degradation of hip-his-leu ( Figure 2 ). The total activity of the degradation of hip-his-leu consists of a lisinopril-dependent activity (that is ACE activity) and lisinopril-independent activity (that is 'ACE-like' activity), which is performed by peptidase(s) different from ACE (Table 1, Figure 2 ). ACE activity accounts for about 30% of the total activity.
TGF-β 1 induces the degradation of hip-lis-leu
TGF-β 1 (10 ng/ml) increased significantly (and to the same extent) both the lisinopril-dependent and lisinopril-independent degradation of hip-hisleu in fibroblasts cultured for seven days (Table 1) .
Lisinopril inhibited, in a similar way and to the same extent, the degradation of hip-his-leu in both control and TGF-β 1 -treated fibroblasts (Table 1, Figure 2 ). ACE activity increased 4.5-fold from 7.1 ± 0.6 to 30.7 ± 5.1 pmol/(min x 10 6 cells) in TGFβ 1 -exposed fibroblasts (p=0.005) ( Table 1 ).
Figure 3
Western blotting of ACE and α-SMA in lysates of fibroblasts cultured for seven days in a DMEM medium supplemented with 10% foetal bovine serum with(out) 10 ng/ml TGF-β 1 . Primary antibodies are mouse anti-ACE monoclonal antibody and mouse anti-α-SMA monoclonal antibody. Horseradish peroxidase-conjugated goat antimouse IgG is used as secondary antibody. Lane 1 -control fibroblasts; Lane 2 -TGF-β 1 -treated fibroblasts. 
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His-leu degradation
His-leu is a substrate for some peptidases 47, 54 and the degradation of this dipeptide in cell cultures is a possible cause for the underestimation of ACE activity. Therefore, the effect of various peptidase inhibitors on the his-leu concentration in homogenates of fibroblasts was tested. No effect on the his-leu degradation was found in the presence of high concentrations of antipain (20 µM), aprotinin (1 µM), bestatin (100 µM), chymostatin (50 µM), diprotin A (100 µM), leupeptin (10 µM), pepstatin (100 µM), phosphoramidon (100 µM), 1,10-phenantroline (1 mM), and phenylmethylsulphonyl fluoride (500 µM) (data not shown). Thus, aminopeptidases, aspartases, calpain, dipeptidylpeptidase IV, endopeptidase 24.11, kallikrein, plasmin and chymase do not degrade his-leu in homogenates of fibroblasts.
Western blotting of ACE and α α-SMA Western blotting (Figure 3 , Table 2 ) showed that adult rat ventricular fibroblasts in second passage, seeded at a density of 2600 cells/cm 2 , contain a small amount of ACE which is increased 6.9-fold by TGF-β 1 . Control cultures of fibroblasts also contain α-SMA; TGF-β 1 induces a 6.8-fold increase in this cytoskeleton protein.
Fibroblast size Size of fibroblasts in culture
Phase-contrast light microscopy showed that TGFβ 1 induced an increase in cell size (Figure 1) .The size and the shape of the fibroblasts depended on the confluence of the cultures. After seven days of incubation, the control cultures of fibroblasts were confluent, or even over-confluent, but the TGF-β 1 -treated cultures were still non-confluent.
In confluent cultures the cells were smaller, rounder and less variable. Therefore, we always compared the cell sizes in cultures with approximately the same degree of confluence (Figure 1 A  and B ).
Size of harvested fibroblasts
After harvesting the fibroblasts with trypsin, they were round in shape. TGF-β 1 induced a 1.5-and 1.85-fold increase in the diameter and volume, respectively, of the fibroblasts in culture (Figure 4 , Table 3 ).
Total protein content of fibroblasts
Control cultures of fibroblasts contained 0.30 ± 0.04 mg of protein per 10 6 cells and TGF-β 1 induced a 2.3-fold increase in the protein content per cell ( Table 3) .
Proliferation of fibroblasts TGF-β 1 and DNA synthesis
TGF-β 1 (10 ng/ml) induced 90% inhibition of the 3 H-thymidine incorporation in fibroblasts in culture for seven days ( Figure 5 ).
TGF-β 1 and number of fibroblasts
As compared with control, TGF-β 1 decreased (p<0.001) dose-dependently the number of fibroblasts cultured for seven days with a maximum effect at 10 ng/ml ( Figure 6 ). There were no indications of cell death in these cultures. The effect of TGF-β 1 on the number of fibroblasts was dependent on the time of incubation. The difference in cell number between controland TGF-β 1 -treated cultures increased (p<0.001) with time of incubation and was maximal after 4-6 days (Figure 7) . 
Proliferation of fibroblasts in the presence of lisinopril and angiotensin II
Lisinopril, at a concentration of 10 µM, did not affect 3 H-thymidine incorporation in TGF-β 1 -treated fibroblasts (378 ± 58 cpm with and 307 ± 32 cpm without lisinopril) or in control fibroblasts (9966 ± 258 cpm with and 10,286 ± 580 cpm without lisinopril). Lisinopril (10 µM) also did not change (p>0.10) the number of fibroblasts in TGFβ 1 -treated cultures (-3.86 ± 6.6%) or in control cultures (0.74 ± 9.9%).
Ang II (1 µM) similarly had no effect on the number of fibroblasts in growing cultures ( Figure  7 ). As shown in Figure 8 , the effect of Ang II on DNA synthesis, measured as 5-Bromo-2'-deoxyuridine (BrdU) incorporation, was not dependent on the time of incubation (from one up to six days).
Discussion
TGF-β β 1 , ACE protein, ACE activity and 'ACElike' activity
Normal rat cardiac tissue remote from blood vessels contains a low density of ACE. 4, 21, 55 Cardiac fibrosis is accompanied by the appearance in the fibrotic tissue of ACE and a high concentration of TGF-β 1 .The latter is a major tissue factor responsible for collagen deposition. 1,2 However, the relationship between ACE and the appearance of TGFβ 1 in the fibrotic tissue is still unknown.
There is also some controversy about the presence of ACE in rat cardiac fibroblasts. Fibroblasts in skeletal muscle do not show ACE. 55, 56 Histochemistry of adult rat cardiac tissue has also shown that fibroblasts in normal interstitium are ACE-negative. 5, 11 However, cultured rat neonatal cardiac fibroblasts contain ACE mRNA and are able to convert angiotensin I (Ang I) to Ang II, this conversion is completely inhibited by captopril. 57, 58 There are, of course, some major differences between neonatal and adult rat cardiac fibroblasts. For instance,Ang II stimulates the proliferation of neonatal fibroblasts, [59] [60] [61] while it has no effect on that of adult cardiac fibroblasts. 44, 62, 63 It has also been shown that myofibroblasts, in contrast to fibroblasts, contain ACE. 7, [9] [10] [11] 64, 65 Activity of the degradation of hip-his-leu by homogenates of fibroblasts in the presence of lisinopril (10 µM) is considered to be due to ACE. In the present study, we have demonstrated that cultures of rat cardiac ventricular fibroblasts contain two types of hip-his-leu degradation activity, namely a lisinopril-dependent activity, that is obviously ACE activity, and a lisinopril-independent activity, that is 'ACE-like' activity, which is performed by peptidase(s) different from ACE (Table 1, Figure 2 ).Thus, cardiac fibroblasts may convert Ang I to Ang II by two independent mechanisms. ACE activity constitutes about 30% of the total activity. Which enzyme(s) besides ACE degrades hip-his-leu in rat cardiac ventricular fibroblasts needs to be further elucidated. It is known that the conversion of Ang I to Ang II can be mediated by different enzymes such as cathepsin A, 66 kallikreinlike enzyme(s), 67 tonin, 68, 69 chymotrypsin-like proteinase, 69 human cardiac fibroblast chymase, 70, 71 and cathepsin G. 69, 72 The type of enzyme(s) which, in our experiments, degraded hip-his-leu independently of ACE is under current investigation.
ACE activity and the quantity of ACE protein in cardiac fibroblasts is increased 4.5-and 6.9-fold, respectively, by the presence of TGF-β 1 ( Table 2) .The difference between the induction of the activity and the quantity of the enzyme is not significant.These data indicate that TGF-β 1 increases the cellular activity of ACE via induction of ACE synthesis.
TGF-β 1 induces a lisinopril-independent 'ACElike' activity as well as ACE activity.TGF-β 1 does not change the ratio between lisinopril-dependent and Figure 7 Effect of TGF-β 1 and Ang II on the cell number in cultures of rat cardiac ventricular fibroblasts. Fibroblasts are cultured in a DMEM medium supplemented with 10% foetal bovine serum with(out) 10 ng/ml TGF-β 1 or 1 µM Ang II. Cells are harvested after one, four, five, and six days and cell number is determined with a microtiter tetrazolium assay,WST-1. = control fibroblasts; = Ang IItreated fibroblasts;
= TGF-β 1 -treated fibroblasts. lisinopril-independent degradation of hip-his-leu.The similarity of the increase in both activities may indicate an identical mechanism by which they are induced.To elucidate further the mechanism of the regulation of ACE by TGF-β 1 and the cell type in which the enzyme is localised, we have studied the effect of TGF-β 1 on the fibroblast phenotype.
α α-Smooth Muscle Actin
Western blotting showed that control cultures of rat ventricular fibroblasts, incubated with 10% foetal bovine serum (FBS) and seeded at a rather low cells density (2600 cells/cm 2 ), contain α-SMA (Figure 3 ). Among fibroblast-like cells, only myofibroblasts contain filaments of α-SMA, which is a marker of this cell phenotype. 18 Therefore, the presence of α-SMA indicates that our fibroblast cultures were heterogeneous and contained myofibroblasts. Heterogeneity of fibroblast cultures, even from one anatomical site, is well-known. 19, [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] There is, however, some controversy in the literature about the presence of α-SMA, i.e. myofibroblasts, in non-treated cultures of fibroblasts. In some fibroblast cultures, there is no actin at all, 34,44 while others contain α-SMA. 16, 34, 35, 42, 83 Actin is also absent in quiescent cultures incubated in the absence of serum and growth factors 34, 42 and is present in growing cultures, incubated in the presence of serum, which always contains TGF-β 1 . 16, 34, 35 The presence of α-SMA in fibroblasts cultured in the presence of serum has also been found even after cloning of the fibroblasts, suggesting that the expression of α-SMA is a constitutive feature of a population of fibroblasts cultured in the presence of serum. 77 The quantity of α-SMA in growing fibroblast cultures is also strongly enhanced with a decrease in cell density seeding. 16 It can be related to the concentration of TGFβ 1 in the medium, because fibroblasts seeded at a low density secrete TGF-β 1 more actively than those seeded at a high density. 16 In the present study, the fibroblasts were always seeded at a rather low density and cultured in the presence of FBS.
TGF-β β 1 and α α-SMA
The quantity of α-SMA in rat cardiac fibroblasts, cultured in the presence of TGF-β 1 , was increased approximately seven-fold compared with control ( Table 2 ). These data are compatible with those obtained in fibroblasts of different species and tissues. 34, 35, 42, 53, 85 It has previously been shown that, after 48 hours of incubation of subconfluent cultures of fibroblasts in the presence of 10% FBS and TGF-β 1 , 95% of the total population of the cells are myofibroblasts. 42 In our experiments, where growing cultures of fibroblasts were incubated with 10% FBS and TGF-β 1 for seven days, probably 100% of the cells were myofibroblasts. If this is true, it can be suggested that myofibroblasts constitute about 14% of our control cultures.
Myofibroblasts, desmin and vimentin
Myofibroblasts, like fibroblasts, always contain vimentin and, in addition, often express other cytoskeletal proteins specific for myogenic cells, such as α-SMA and desmin. Four types of myofibroblasts have been identified in different pathologic settings: only vimentin, V-type; vimentin and α-SMA, VA-type; vimentin and desmin, VD-type; vimentin,α-SMA and desmin,VAD-type. 17, 18 Rat ventricular myofibroblasts isolated from scars after an MI are characterised by the presence of vimentin, α-SMA and desmin and are thus of the VAD-type. 65 However, in the present study no desmin was present, either in the control or in the TGF-β 1 -treated cultures of ventricular fibroblasts, while TGF-β 1 increased seven-fold the quantity of α-SMA (Table 2, Figure 3 ).This suggests that TGF-β 1 induced the differentiation of cultured rat ventricular fibroblasts to the VA-type of myofibroblasts.Thus, myofibroblasts differentiated in the presence of TGF-β 1 from rat ventricular fibroblasts in our experiments (VA-type) are different from the myofibroblasts located in scars (VAD-type) of infarcted rat heart.
It has been suggested that myofibroblasts can originate from different muscle and non-muscle cells. 18 It is possible that rat ventricular myofibroblasts from scars do not stem from ventricular fibroblasts, such as those in our experiments, but from other cells. Another possibility is that scar myofibroblasts may originate from fibroblasts, but that some additional stimuli induce the expression of desmin on top of the TGF-β 1 presence. 18
TGF-β β 1 and cell size
Myofibroblasts originating from cardiac fibroblasts, cultured in the presence of TGF-β 1 , were larger than original fibroblasts and contained more cell protein; both variables were increased about two-fold (Table 3 ). It has been previously found that myofibroblasts cultured or taken from pathogenic tissues are larger than fibroblasts taken from normal tissues [12] [13] [14] [15] [16] and contain more protein. 16 It has also been previously demonstrated that rabbit cardiac fibroblasts, when exposed to TGF-β 1 give rise, in subsequent passages, to a second generation of cells that are considerably enlarged. 34 TGF-β β 1 and cell proliferation TGF-β 1 inhibited 3 H-thymidine incorporation in cardiac fibroblasts actively proliferating in the presence of 10% FBS and decreased the cell number in these cultures, with a maximal effect at 10 ng/ml ( Figures 6, 7, 8) , comparable with the results of Desmoulière et al. 35 The proliferation of rat ventricular fibroblasts is therefore under control of TGF-β 1 , as in many other cell types. 86 It is possible that myofibroblasts, which appear in cultures of fibroblasts in the presence of TGFβ 1 , proliferate more slowly than the original fibroblasts. It has, indeed, been demonstrated that rabbit cardiac fibroblasts exposed to TGF-β 1 proliferate more slowly in subsequent passages as compared with the primary cells. 34 
Mechanisms of ACE induction by TGF-β β 1
Our data show that TGF-β 1 induced the differentiation of cultured rat ventricular fibroblasts to myofibroblasts and that this differentiation is accompanied by an increase in ACE protein in the culture (Table 2, Figure 3 ). It has been mentioned above that α-SMA in control cultures is confined to myofibroblasts, which comprise about 14% of the total population in culture. TGF-β 1 increases the quantity of ACE and α-SMA protein in fibroblast cultures to the same extent ( Table 2 ).This similar increase in both proteins may be the result of an identical mechanism by which they are induced.We suggest that ACE and α-SMA belong to the small population of myofibroblasts. The existence of a small population of myofibroblasts in control cultures probably depends on the presence of some TGF-β 1 in the conditioned medium, since TGF-β 1 is present in serum and can be secreted from fibroblasts.To have homogeneous control cultures of fibroblasts that do not contain myofibroblasts, we have to exclude TGF-β 1 from the medium. Suitable tools for this purpose are decorin or anti-TGF-β antibodies. Decorin and neutralising antibodies can also provide evidence supporting the engagement of TGF-β-specific receptors in the appearance of myofibroblasts. TGF-β 1 is able to enhance, to the same extent, the cell quantity of ACE and α-SMA via an increase in the number of myofibroblasts and, therefore, an increase in the ratio between the quantities of myofibroblasts and fibroblasts in culture. TGF-β 1 can then augment similarly the cell quantity of both proteins via an increase in the number of myofibroblasts and, therefore, an increase in the ratio between the quantities of myofibroblasts and fibroblasts in culture. The same mechanism can probably also explain the similar TGF-β 1 -induced stimulation of both the lisinopril-dependent and lisinopril-independent degradation of hip-his-leu.
It has previously been mentioned that Ang II induces the synthesis of TGF-β 1 in various cells such as cardiac fibroblasts, [26] [27] [28] [29] [30] [31] renal tubular cells, 8 and VSMC. 87 The cellular effects of Ang II and TGFβ 1 are thus complementary: Ang II induces the synthesis of TGF-β 1 in ventricular fibroblasts and TGF-β 1 , in turn, induces ACE, as a tool for Ang II synthesis. Moreover, the effects of Ang II and TGFβ 1 are also complementary in vivo. Both of them are inducers of tissue fibrosis which, independently of the primary stimulus, is accompanied by high tissue concentrations of both Ang II 8 and TGFβ 1 , 1,2 and by the appearance of ACE and myofibroblasts. 1, 2, [5] [6] [7] 11 Thus, these factors could create a vicious circle in the fibrotic tissue.
Lisinopril and proliferation of fibroblasts
It has been shown in prevention and interventional trials, that treatment of rats with ACEinhibitors prevents, reduces or regresses myocardial accumulation of fibrous tissue (see review 88 ). ACE inhibitors could inhibit fibrosis development via proliferation and/or extracellular matrix secretion by fibroblasts. However, no effect of the ACE inhibitor, lisinopril, on the 3 H-thymidine incorporation and the cell number in cultures of cardiac fibroblasts has been found in the present study. These findings are not compatible with the data of Van Krimpen et al., 89 who show that treatment of rats with the ACE inhibitor captopril inhibits the stimulation of cardiac fibroblast proliferation in the interstitium after MI. However, this inhibitory effect of captopril is probably not related to ACE activity. Indeed, it has been found that captopril and penicillamine, two thiol-containing compounds with and without inhibitory activity on ACE, both inhibit the proliferation of lung fibroblasts in cultures. 90 Absence of the influence of lisinopril on the proliferation of adult rat cardiac fibroblasts is compatible with the absence of any effect of Ang II added to these cells. 44, 62, 63 As Ang II is able to induce collagen in adult cardiac fibroblasts, 44, 62, 63 we suggest that lisinopril may affect collagen synthesis in rat ventricular myofibroblasts, which, as we have shown, contain ACE.This hypothesis has however to be further elucidated.
